ACE-031 is an experimental, non-approved peptide that was studied in clinical trials for its potential therapeutic benefits in conditions involving muscle wasting
Potential Benefits (Observed in Research)
Research in human trials, indicated several potential benefits stemming from ACE-031's mechanism of action as a myostatin and activin inhibitor:
Increased Muscle Mass and Strength: The primary observed benefit was significant muscle hypertrophy (increase in muscle fiber size) and a corresponding increase in muscle mass and function in animal models. In a human trial, subjects experienced statistically significant increases in total body lean mass and thigh muscle volume.
Improved Bone Density: Studies suggested that ACE-031 treatment led to increased bone mineral density and enhanced bone strength, potentially by affecting bone metabolism and decreasing bone resorption.
Reduced Fat Mass: Research indicated that increasing muscle mass via ACE-031 might lead to a corresponding decrease in fat mass and improvements in overall metabolic function.
Therapeutic Potential for Diseases: ACE-031 showed promise as a potential therapy for neuromuscular diseases such as Duchenne muscular dystrophy (DMD) and amyotrophic lateral sclerosis (ALS), which are characterized by severe muscle loss.
ACE-031 is an experimental, non-approved peptide that was studied in clinical trials for its potential therapeutic benefits in conditions involving muscle wasting
Potential Benefits (Observed in Research)
Research in human trials, indicated several potential benefits stemming from ACE-031's mechanism of action as a myostatin and activin inhibitor:
Increased Muscle Mass and Strength: The primary observed benefit was significant muscle hypertrophy (increase in muscle fiber size) and a corresponding increase in muscle mass and function in animal models. In a human trial, subjects experienced statistically significant increases in total body lean mass and thigh muscle volume.
Improved Bone Density: Studies suggested that ACE-031 treatment led to increased bone mineral density and enhanced bone strength, potentially by affecting bone metabolism and decreasing bone resorption.
Reduced Fat Mass: Research indicated that increasing muscle mass via ACE-031 might lead to a corresponding decrease in fat mass and improvements in overall metabolic function.
Therapeutic Potential for Diseases: ACE-031 showed promise as a potential therapy for neuromuscular diseases such as Duchenne muscular dystrophy (DMD) and amyotrophic lateral sclerosis (ALS), which are characterized by severe muscle loss.
When purchasing this item, don't forget your Bac Water and Syringes
